Department of Obstetrics and Gynecology, Klinikum Wolfsburg, Wolfsburg, Germany.
Department of Obstetrics, Gynecology and Reproductive Medicine, Medical Hannover School, Hannover, Germany.
BMC Infect Dis. 2021 Jul 2;21(1):634. doi: 10.1186/s12879-021-06139-y.
The introduction of human papillomavirus (HPV) vaccination has resulted in a remarkable decline of genital warts in women and men, but in Germany historical rates of vaccination are relatively low. We report long-term surveillance data on changes in HPV 6 and HPV 11 infection and the prevalence of genital warts in young women in the Wolfsburg HPV epidemiological study (WOLVES).
Women born in 1983/84, 1988/89, and 1993/94 participated in four cohorts between 2009/10 and 2014/15. Quadrivalent vaccination coverage and prevalence of HPV 6/11 infection and genital warts are reported for participants aged 19-22 years and 24-27 years at the time of sample collection. Statistical analyses were done to compare similarly aged participants using 2 × 2 contingency tables (Röhmel-Mansmann unconditional exact test; two-side alpha of 0.05).
A total of 2456 women were recruited. Between 2010 and 2015, there was a statistically significant decrease in the prevalence of HPV 6 infection among women aged 24-27 years (2.1% versus 0.0%; P < 0.0001) and women aged 19-22 years (2.0% versus 0.0%; P = 0.0056). There was no significant decline in HPV 11 infection. In total, 52 of 2341 participants were diagnosed with genital warts. There was a statistically significant drop in the risk of developing genital warts in women aged 24-27 years between 2010 and 2015 (4.7% versus 1.7%, respectively; P = 0.0018). The overall risk of developing genital warts in women aged 19-27 years decreased from 3.1% in 2010 to 1.2% in 2015 (P = 0.0022).
An increase in vaccination coverage was associated with a decreased prevalence of genital warts in young women. A protective effect greater than herd immunity alone was seen despite low vaccination rates. Quadrivalent vaccine had a protective effect on genital HPV 6 infection and an almost fully protective effect on the development of genital warts in the youngest population.
人乳头瘤病毒(HPV)疫苗的引入导致女性和男性生殖器疣的发病率显著下降,但德国的疫苗接种历史相对较低。我们报告了沃尔夫斯堡 HPV 流行病学研究(WOLVES)中年轻女性 HPV 6 和 HPV 11 感染和生殖器疣流行率的长期监测数据。
1983/84 年、1988/89 年和 1993/94 年出生的女性参加了 2009/10 年至 2014/15 年期间的四个队列研究。报告了四价疫苗接种覆盖率以及 19-22 岁和 24-27 岁参与者的 HPV 6/11 感染和生殖器疣的流行率。使用 2×2 列联表(Röhmel-Mansmann 无条件精确检验;双侧 alpha 值为 0.05)比较相似年龄的参与者。
共招募了 2456 名女性。2010 年至 2015 年间,24-27 岁女性(2.1%比 0.0%;P<0.0001)和 19-22 岁女性(2.0%比 0.0%;P=0.0056)中 HPV 6 感染的流行率呈统计学显著下降。HPV 11 感染没有显著下降。共有 2341 名参与者中的 52 名被诊断为生殖器疣。2010 年至 2015 年间,24-27 岁女性生殖器疣发病风险呈统计学显著下降(分别为 4.7%和 1.7%;P=0.0018)。19-27 岁女性生殖器疣的总体发病风险从 2010 年的 3.1%下降到 2015 年的 1.2%(P=0.0022)。
疫苗接种覆盖率的增加与年轻女性生殖器疣的流行率降低有关。尽管疫苗接种率较低,但仍观察到了比群体免疫更大的保护作用。四价疫苗对生殖器 HPV 6 感染有保护作用,对最年轻人群生殖器疣的发展有几乎完全的保护作用。